(E)-Cefuroxime Axetil

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

69 API Suppliers, 38 USDMF, 20 CEP/COS, 1 JDMF, 8 EU WC, 22 KDMF, 4 NDC API, 18 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

4 Drugs in Development

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers, 34 FDA Orange Book, 217 Europe, 7 Canada, 9 South Africa, 94 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML, FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML

RELATED EXCIPIENT COMPANIES

3 Evonik, 4 Rochem International Inc, 20 SPI Pharma, 1 Pharm-RX Chemical, 3 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 Kirsch Pharma, 1 Cerata Pharmaceuticals LLP, 11 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 8 Actylis, 2 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 19 BASF, 1 CD Formulation, 2 Clariant, 12 Corel Pharma Chem, 3 DFE Pharma, 1 Esteem Industries, 2 Finar, 9 Gangwal Chemicals, 1 Gloria Interchem, 8 Ideal Cures, 4 Ingredion Pharma Solutions, 1 JJ Chemicals, 11 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 14 Microlex e.U, 1 Nanjing Bold Chemical, 3 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

67 Fillers, Diluents & Binders, 57 Coating Systems & Additives, 30 Direct Compression, 28 Thickeners and Stabilizers, 26 Controlled & Modified Release, 26 Lubricants & Glidants, 25 Solubilizers, 23 Taste Masking, 21 Chewable & Orodispersible Aids, 20 Disintegrants & Superdisintegrants, 19 Topical, 19 Granulation, 18 Parenteral, 16 Co-Processed Excipients, 15 Film Formers & Plasticizers, 11 Emulsifying Agents, 9 API Stability Enhancers, 6 Rheology Modifiers, 6 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

14 News #PharmaBuzz

14 News #PharmaBuzz

GLOBAL SALES INFORMATION

7 US Medicaid Prescriptions, 27 Regulatory FDF Prices

MARKET PLACE

26 APIs, 30 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 USP, 7 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

(E)-Cefuroxime Axetil

Filters

FILTER :

filter Company Reset all filters

4 All

01 4Seppic

filter Capability Reset all filters

filter Country Reset all filters

01

Seppic

SEPIFILM CLASSIC RANGE

Health 2.0 Conference

Not Confirmed

02

Seppic

SEPIFILM PW RANGE

Health 2.0 Conference

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for (E)-Cefuroxime Axetil? Find Coloring Agents used in (E)-Cefuroxime Axetil to address drug delivery challenges on PharmaCompass.

(E)-Cefuroxime Axetil

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

69 API Suppliers

38 USDMF

20 CEP/COS

1 JDMF

8 EU WC

22 KDMF

4 NDC API

18 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

4 Drugs in Development

FINISHED DOSAGE FORMULATIONS

361 FDF Dossiers

34 FDA Orange Book

217 Europe

7 Canada

9 South Africa

94 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 125MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

FOR SUSPENSION;ORAL - EQ 125MG BASE/5ML

FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML

RELATED EXCIPIENT COMPANIES

3 Evonik

4 Rochem International Inc

20 SPI Pharma

1 Pharm-RX Chemical

3 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

4 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 Kirsch Pharma

1 Cerata Pharmaceuticals LLP

11 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

8 Actylis

2 Aeon Procare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

19 BASF

1 CD Formulation

2 Clariant

12 Corel Pharma Chem

3 DFE Pharma

1 Esteem Industries

2 Finar

9 Gangwal Chemicals

1 Gloria Interchem

8 Ideal Cures

4 Ingredion Pharma Solutions

1 JJ Chemicals

11 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

14 Microlex e.U

1 Nanjing Bold Chemical

3 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

1 Novo Excipients

1 Pharmatrans-Sanaq

5 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

20 Roquette

14 Seppic

8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

10 Sigachi Industries

TABLET;ORAL - EQ 125MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 250MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - EQ 500MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons